Managing Diabetic Peripheral Neuropathic Pain
|
|
- Ruth Atkinson
- 5 years ago
- Views:
Transcription
1 Managing Diabetic Peripheral Neuropathic Pain Juzar Hooker Consulting Neurologist, Aga Khan University Hospital, Nairobi
2 Disclosure Eli lilly (have not driven, reviewed or controlled the presentation)
3
4
5 IASP; Tesfaye et al 2010 Definition Pain arising as a direct consequence of abnormalities in the peripheral somatosensory system in people with diabetes No nociceptive stimulus Neuronal hyperexcitability
6 Common problem Up to 50% people with diabetes over time develop neuropathy 3-25% develop painful diabetic peripheral sensory neuropathy 47.5% of diabetic foot ulcers at KNH were neuropathic, and 30% neuroischaemic Tesfaye et al 2011; Nyamu et al 2003
7
8 Risk of Peripheral Neuropathy Increases with Longer Duration of Diabetes 100 Prevalence of Distal Polyneuropathy by Duration of Type 2 Diabetes % of Patients Duration of Diabetes (Years) DPNP Adapted from: Eastman. In: NIDDK, 1995.
9
10
11
12
13
14
15
16
17 Key Mechanisms in the Development of Chronic Pain 3. Sensitization of neurons in the brain 1 2. Sensitization and amplification of peripheral input in the dorsal horn 2 1. Sensitization and abnormal peripheral input 2 DPNP 1. Baron. Nat Clin Pract Neurol 2006;2(2): Latremoliere et al. J Pain 2009;10(9): Image courtesy of Apollo Marcom.
18 Diabetic Peripheral Neuropathy Clinical Stages DPN is a progressive disease starting with diminished nerve conduction velocity and ending with amputation Symptoms occur in approximately 25% of patients and may occur any time and/ or intermittently Symptoms (numbness, prickling, pain) Amputation Signs and Symptoms Foot ulcer Pressure sensation, temperature sensation Reflexes Vibratory sensation Nerve conduction velocity Subclinical Time Clinical DPNP Vinik et al. Diabetologia 2000;43(8):
19
20 Boulton 2005
21 Boulton 2005
22
23
24 Diabetic Patients Should be Screened DPNP for Neuropathy (Provisional Diagnosis) History/physical exam Inspect for deformities, skin changes Assess symptoms Neurological exam Pressure sensation (monofilament) Muscle stretch reflexes Vibration testing Proprioception Pain sensation (pin prick) Monofilament screening test Boulton et al. Diabet Med 1998;15(6): Boulton et al. Diabetes Care 2004;27(6): Light touch sensation Muscle strength Confirmatory testing Nerve conduction studies Quantitative sensory testing
25 A Boulton 2005
26 Pain Severity Numeric Rating Scale Average Pain, Worst Pain, and Night Pain Pain severity No Pain Measured by an 11- point numeric rating scale Completed by the patient daily to measure the severity of pain Average pain (primary efficacy measure) Worst pain Night pain Scores range from 0 (no pain) to 10 (worst possible pain) Worst Possible Pain
27
28 Goals of Neuropathic Pain Treatment Primary goal: reduction in pain 1,2 Secondary goals 1,2 Improvement in physical function Reduction in affective distress Improvement in quality of life Maintenance of positive outcomes Education of patient and providers Achieving these goals depends upon 1 Accurate diagnosis of any underlying etiology Preventive treatment of underlying etiology (eg, diabetes and joint inflammation) DPNP 1. Argoff et al. Mayo Clin Proc 2006;81(4 Suppl):S Turk. Clinical Journal of Pain 2000;16:
29 Nutritional deficiency B12 Boulton 2005
30
31
32
33
34
35
36
37
38
39
40 AAN
41
42
43 Global Pharmacological Treatment Guidelines for Neuropathic Pain Including DPNP Medication Class TCAs Including amitriptyline (AMT) Ca Channel α 2 - δ Ligands (gabapentin, pregabalin) SNRIs (duloxetine, venalfaxine) Topical lidocaine Opioid analgesics and tramadol IASP/ NeuPSIG 1 1 st line 1 st line 1 st line 1 st line Canadian Pain Society 2 EFNS 3 NICE 4 JSPC 5 1 st line for PPN, PHN, CP 1 st line for PPN, PHN, CP 1 st line 2 nd line 2 nd line for PPN 1 st line for localized NP 2 nd line except in select circumstances 2 nd line for localized NP 3 rd line 1 st line for PHN if small area of pain/allodynia 2 nd line for PPN, PHN, CP AMT 1 st line, 2 nd line for DPNP and other TCAs if AMT fails Pregabalin 1 st line, 2 nd line for DPNP Duloxetine 1 st line for DPNP 1 st line 1 st line 2 nd line 3 rd line NA 3 rd line 3 rd line DPNP 1. Dworkin et al. Pain 2007;132(3): Moulin et al. Pain Res Manag 2007;12(1): Attal et al. Eur J Neurol 2010;17(9):1113-e88 4. NICE Neuropathic Pain Clinical Guidelines Hosokawa et al. JSPC 2011.
44
45
46 In summary Look for (painful) diabetic neuropathy Exclude other possibilities Optimize glycaemic control and vascular risk Consider Non- pharmacologic therapy Topical therapy Systemic pharmacologic therapy Start low, go slow Choice of drug Monitor therapy Modify treatment Quality of life Foot care
IF I M NOT TREATING WITH OPIOIDS, THEN WHAT AM I SUPPOSED TO USE?
NON-OPIOID TREATMENT OPTIONS FOR CHRONIC PAIN Alison Knutson, PharmD, BCACP Medication Management Pharmacist Park Nicollet Creekside Clinic Dr. Knutson indicated no potential conflict of interest to this
More informationDiabetic Peripheral Neuropathy: Assessment and Treatment
Diabetic Peripheral Neuropathy: Assessment and Treatment Denise Soltow Hershey PhD, FNP-BC Michigan Council of Nurse Practitioners Annual Conference March 17, 2018 Objectives 1) Describe the clinical features
More informationSpinal Cord Injury Pain. Michael Massey, DO CentraCare Health St Cloud, MN 11/07/2018
Spinal Cord Injury Pain Michael Massey, DO CentraCare Health St Cloud, MN 11/07/2018 Objectives At the conclusion of this session, participants should be able to: 1. Understand the difference between nociceptive
More informationNeuropathic Pain in Palliative Care
Neuropathic Pain in Palliative Care Neuropathic Pain in Advanced Cancer Affects 40% of patients Multiple concurrent pains are common Often complex pathophysiology with mixed components Nocioceptive Neuropathic
More informationApproaches to Managing Neuropathic Pain. Nov 7, 2017
1 Approaches to Managing Neuropathic Pain Nov 7, 2017 3 Learning objectives Review the current Canadian Guidelines on Neuropathic Pain Review the diagnosis and options available for the management of Neuropathic
More informationBrian Kahan, D.O. FAAPMR, DABPM, DAOCRM, FIPP Center for Pain Medicine and Physiatric Rehabilitation 2002 Medical Parkway Suite 150 Annapolis, MD
Brian Kahan, D.O. FAAPMR, DABPM, DAOCRM, FIPP Center for Pain Medicine and Physiatric Rehabilitation 2002 Medical Parkway Suite 150 Annapolis, MD 1630 Main Street Suite 215 Chester, MD 410-571-9000 www.4-no-pain.com
More informationTUE Physician Guidelines Medical Information to Support the Decisions of TUE Committees Neuropathic Pain
1. Medical Condition Neuropathic pain is defined as pain that results from a lesion or disease in the somatosensory system. Neuropathic pain is frequently difficult to treat, and commonly interferes with
More informationAssessment of Painful Diabetic Peripheral Neuropathy (pdpn):
Assessment of Painful Diabetic Peripheral Neuropathy (pdpn): An Essential Part of the Diabetic Foot Exam Pfizer Medical Affairs Objectives Review the epidemiology, burden, pathophysiology, and clinical
More informationPainful Diabetic Neuropathy Effective Management. Ketan Dhatariya Consultant in Diabetes NNUH
Painful Diabetic Neuropathy Effective Management Ketan Dhatariya Consultant in Diabetes NNUH Neuropathic Pain Prevalence varies between 10 and 90% depending on classification Accounts for 50-75% of non-traumatic
More informationPAIN EDUCATION Module 5: Neuropathic pain
PAIN EDUCATION Module 5: Neuropathic pain 2013 Excerpta Medica BV The material presented in this teaching slide deck is for educational purposes only. If you wish to reproduce, transmit in any form or
More informationManagement of Pain related to Spinal Cord Lesion
Management of Pain related to Spinal Cord Lesion A Neurologist s Perspective Vincent Mok, MD Associate Professor Division of Neurology Department of Medicine and Therapeutics The Chinese University of
More informationA review of Neuropathic Pain: From Guidelines to Clinical Practice
Pain Ther (2017) 6 (Suppl 1):S35 S42 DOI 10.1007/s40122-017-0087-0 REVIEW A review of Neuropathic Pain: From Guidelines to Clinical Practice Giorgio Cruccu. Andrea Truini Received: October 12, 2017 Ó The
More informationDIAGNOSIS OF DIABETIC NEUROPATHY
DIAGNOSIS OF DIABETIC NEUROPATHY Dept of PM&R, College of Medicine, Korea University Dong Hwee Kim Electrodiagnosis ANS Clinical Measures QST DIAGRAM OF CASUAL PATHWAYS TO FOOT ULCERATION Rathur & Boulton.
More informationRoadmap: PIFP and PTTN
Persistent Idiopathic Facial Pain & Painful Traumatic Trigeminal Neuropathy Dr. Rafael Benoliel Professor, Department of Diagnostic Sciences Rutgers School of Dental Medicine USA No Disclosures Roadmap:
More informationI s s u e 1,
I s s u e 1, 2 0 1 4 Guidelines for the Pharmacological Treatment of Peripheral Neuropathic Pain: Expert Panel Recommendations for the Middle East Region EFNS guidelines on the pharmacological treatment
More information8/28/2012. Disclosure. Accreditation. Neuropathic Pain: Overview and Management. Pharmacists: L01-P
Neuropathic Pain: Overview and Management Shyam Gelot, Pharm.D. Assistant Professor University of South Florida College of Pharmacy September 8, 2013 Disclosure I have nothing to disclose concerning possible
More informationManaging Pain in the Elderly
Managing Pain in the Elderly MILES BELGRADE, MD COMPREHENSIVE PAIN CENTER MINNEAPOLIS VA The Pain Deck is Stacked Against the Elderly Osteoporosis Fractures 1 Zoster & PHN Trigeminal Neuralgia Verne 81-year-old
More informationNovember 16-18, 2017 Hotel Monteleone New Orleans, LA. Provided by
November 16-18, 2017 Hotel Monteleone New Orleans, LA Provided by Diabetic Neuropathy: A Global and Growing Problem John D. England, MD Louisiana State University Health Sciences Center School of Medicine
More informationSmall Fiber Neuropathies
Small Fiber Neuropathies Charles E. Argoff, M.D. Professor of Neurology Albany Medical College Director, Comprehensive Pain Center Albany Medical Center Disclosure Consultant Independent Contractor: Astra
More informationDiabetic Painful Neuropathy. Prash Vas Consultant in Diabetes and Diabetes Foot Medicine Kings College Hospital, London
Diabetic Painful Neuropathy Prash Vas Consultant in Diabetes and Diabetes Foot Medicine Kings College Hospital, London Background Diabetic peripheral neuropathic pain (DPPN) is a disabling complication
More informationMANAGEMENT OF DIABETIC NEUROPATHY. Chungnam University Hospital Soo-Kyung, Bok, M.D., Ph.D.
MANAGEMENT OF DIABETIC NEUROPATHY Chungnam University Hospital Soo-Kyung, Bok, M.D., Ph.D. The Diabetic neuropathy cannot be reversed Not to restore function to damaged nerve Slowly progress no initial
More informationDiabetic Retinopathy and Neuropathy: 2018 Clinical Practice Guidelines
Diabetic Retinopathy and Neuropathy: 2018 Clinical Practice Guidelines Richard Arakaki, M.D. Phoenix Area Diabetes Consultant August 9 th 2018 Disclose no conflict of interest Complications and Co-morbidities
More informationMr. LBP: Case Presentation
CLINICAL CASES Case: Mr. LBP Mr. LBP: Case Presentation Mr. LBP is a 35-year-old male He fell down while participating in a recreational sports activity He subsequently developed low back pain Upon arrival
More informationKim Chong Hwa MD,PhD Sejong general hospital, Division of endocrine & metabolism
Kim Chong Hwa MD,PhD Sejong general hospital, Division of endocrine & metabolism st1 Classification and definition of diabetic neuropathies Painful diabetic peripheral neuropathy Diabetic autonomic neuropathy
More informationManagement of Neuropathic Pain
MANAGEMENT Goals of Treatment Management of Neuropathic Pain Diagnosis Improved physical functioning Improved psychological state Treatment of underlying conditions Pharmacological and non-pharmacological
More informationDiagnosis of Neuropathic Pain. Didier Bouhassira
Diagnosis of Neuropathic Pain Didier Bouhassira INSERM U-792 Centre d Evaluation et de Traitement de la Douleur Hôpital Ambroise Paré, Boulogne-Billancourt FRANCE BPS, June 7, Brussels Definition Pain
More informationDisclosures. Objectives 9/8/2015
The Aftermath of the Decade of Pain: Alternatives to Opioids in Chronic Pain Management Julie Cunningham, PharmD, BCPP Disclosures No relevant financial disclosures I will discuss off-label uses of antiepileptics,
More informationPractical upates in Diabetes & CV risk management: Brief Updates Neurological complications in diabetes
Practical upates in Diabetes & CV risk management: Brief Updates Neurological complications in diabetes Slides presented during CDMC in Almaty, Kazakhstan on Sunday April 13, 2014 and prepared by: Boris
More informationThe clinical landscape of painful diabetic neuropathy therapy: perspectives for clinicians from clinical practice guidelines
The clinical landscape of painful diabetic neuropathy therapy: perspectives for clinicians from clinical practice guidelines Clin. Invest. (2012) 2(5), 483 489 Painful diabetic neuropathy (PDN) is highly
More informationSmall Fiber Poluneuropathy: An Update
Small Fiber Poluneuropathy: An Update Charles E. Argoff, M.D. Professor of Neurology Albany Medical College Director, Comprehensive Pain Center Albany Medical Center Disclosures Receive consulting fees
More informationpdpn early screening and management
pdpn early screening and management The Hidden Faces of Diabetes Summit was held in Johannesburg, South Africa, from 20 to 21 September 2014. Organized by Pfizer Middle East and Africa, the interactive
More informationKEYWORDS Diabetes Mellitus, Neuropathic Pain, Pregabalin, Amitriptyline, Randomization, Duloxetine.
A PROSPECTIVE, RANDOMISED, COMPARATIVE STUDY OF EFFICACY AND SAFETY OF PREGABALIN, DULOXETINE AND AMITRIPTYLINE IN PATIENTS OF PAINFUL DIABETIC NEUROPATHY IN A TERTIARY CARE TEACHING HOSPITAL IN RURAL
More informationPDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sat, 03 Nov 2018 09:24:50 GMT) CTRI Number Last Modified On 10/06/2013 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
More informationNational Institute for Health and Care Excellence. Neuropathic pain - pharmacological management Guideline consultation. Stakeholder Comments
National Institute for Health and Care Excellence Neuropathic pain - pharmacological management Guideline consultation Stakeholder Comments Please enter the name of your registered stakeholder organisation
More informationNeuropathic Pain Treatment Guidelines
Neuropathic Pain Treatment Guidelines Background Pain is an unpleasant sensory and emotional experience that can have a significant impact on a person s quality of life, general health, psychological health,
More informationTreatment of Neuropathic Pain: What Does the Evidence Say? or Just the Facts Ma am
Treatment of Neuropathic Pain: What Does the Evidence Say? or Just the Facts Ma am Tim R Brown, PharmD, BCACP, FASHP Director of Clinical Pharmacotherapy Cleveland Clinic Akron General Center for Family
More informationPeripheral Neuropathy
Peripheral Neuropathy Neuropathy affects 30-50% of patient population with diabetes and this prevalence tends to increase proportionally with duration of diabetes and dependant on control. Often presents
More informationThe Internist s Approach to Neuropathy
The Internist s Approach to Neuropathy VOLKAN GRANIT, MD, MSC ASSISTANT PROFESSOR OF NEUROLOGY NEUROMUSCU LAR DIVISION UNIVERSITY OF MIAMI, MILLER SCHOOL OF MEDICINE RELEVANT DECLARATIONS Financial disclosures:
More informationPAINFUL DIABETIC NEUROPATHY
PAINFUL DIABETIC NEUROPATHY Content Painful diabetic neuropathy (PDN): painful consequences of diabetes Mechanisms of neuropathic pain in PDN Diagnosis and management of PDN PDN treatment: guidance from
More informationDIABETIC NEUROPATHY ASSESSED AT TWO TIME POINTS FIVE YEARS APART
1 University Department of Neurology, Sarajevo Clinical Center, Sarajevo, Bosnia and Herzegovina 2 Zenica Cantonal Hospital, Zenica, Bosnia and Herzegovina 3 Department of Hemodialysis, Sarajevo Clinical
More informationNeuropathic Pain. Scott Magnuson, MD Pain Management of North Idaho, PLLC
Neuropathic Pain Scott Magnuson, MD Pain Management of North Idaho, PLLC Pain is our friend "An unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described
More informationA Practical Approach to Polyneuropathy SLOCUM DICKSON ANNUAL TEACHING DAY NOVEMBER 4, 2017
A Practical Approach to Polyneuropathy SLOCUM DICKSON ANNUAL TEACHING DAY NOVEMBER 4, 2017 Disclosures Research support from Cytokinetics, Inc Catalyst, Inc Editorial fees from UptoDate. Objectives Describe
More informationIs Neuropathy the root of all evil in the diabetic foot?
Is Neuropathy the root of all evil in the diabetic foot? Andrew J M Boulton, Manchester UK and Miami, FL Vice-President and Director of International Postgraduate Education, EASD The Global Burden of Diabetes
More informationDevelopment Committee
Development Committee Mario H. Cardiel, MD, MSc Rheumatologist Morelia, Mexico Andrei Danilov, MD, DSc Neurologist Moscow, Russia Smail Daoudi, MD Neurologist Tizi Ouzou, Algeria João Batista S. Garcia,
More informationACUTE AND CHRONIC NEUROPATHIES
ACUTE AND CHRONIC NEUROPATHIES American College of Osteopathic Internists Internal Medicine Board Review Course 2018 April 25-29, 2018 Marriott Chicago Downtown Chicago, Illinois Scott Spradlin D.O.,FACP,FACOI
More informationH-reflex and Clinical Examination in the Diagnosis of Diabetic Polyneuropathy
The Journal of International Medical Research 2012; 40: 694 700 H-reflex and Clinical Examination in the Diagnosis of Diabetic Polyneuropathy RO MILLÁN-GUERRERO 1, B TRUJILLO-HERNÁNDEZ 1, S ISAIS-MILLÁN
More information1/21/14. Barriers to Assessment and Management of Chemotherapy- Induced Peripheral Neuropathy. Conflicts of Interest. Learning Objective
Barriers to Assessment and Management of Chemotherapy- Induced Peripheral Neuropathy Connie Visovsky, PhD, RN, ACNP-BC Associate Dean University of South Florida College of Nursing Conflicts of Interest
More informationNeuropathic pain (pain due to nerve damage)
Neuropathic pain (pain due to nerve damage) Clinical Guideline Pain can be nociceptive, neuropathic or mixed. The neuropathic component of pain generally responds poorly to conventional analgesics. Consider
More informationKim Chong Hwa MD,PhD Sejong general hospital, Division of endocrine & metabolism
Kim Chong Hwa MD,PhD Sejong general hospital, Division of endocrine & metabolism Contetns Prevalence of DPN Clinical impacts of DPN Managements of DPN Prevalence of Diabetic peripheral neuropathy in Korea
More informationWork, vibration, & the neurosensory system. Close effects Remote effects Stress and pressure
Work, vibration, & the neurosensory system Close effects Remote effects Stress and pressure Temporary neurosensory effects Reduced sensibility due to: - Temporary threshold shift Reduced motor control
More informationOther classical forms of neuropathic pain include diabetic peripheral neuropathy, trigeminal neuralgia and postherpetic
Guideline Name: Neuropathic Pain Neuropathic pain is defined by the International Association for the Study of Pain, Neuropathic Special Interest group as pain arising as a direct consequence of a lesion
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Neuropathic pain pharmacological management: the pharmacological management of neuropathic pain in adults in non-specialist
More informationOverview of Neuropathic pain
Overview of Neuropathic pain Kongkiat Kulkantrakorn,M.D. Neurology division Thammasat University 1 Contents Overview of pain New concepts and mechanism Treatment options New data in management 2 3 Breaking
More informationNew Developments in the Treatment Algorithm for Peripheral Neuropathic Painpme_
Pain Medicine 2011; 12: S100 S108 Wiley Periodicals, Inc. New Developments in the Treatment Algorithm for Peripheral Neuropathic Painpme_1160 100..108 Oscar de Leon-Casasola, MD School of Medicine and
More informationThe Diabetic Foot Latest Statistics
The Diabetic Foot Latest Statistics There are 2.6 million people with diagnosed diabetes in the UK. There are predicted to be 500,000 who have the condition but are unaware of it. There are 11,859 in TH
More informationFoot Ulcer Workshop: Prevention and Management of Diabetic Foot Ulcers. Aparna Pal, Consultant Endocrinologist, RBH Keith Hilston, Podiatrist, BHFT
Foot Ulcer Workshop: Prevention and Management of Diabetic Foot Ulcers Aparna Pal, Consultant Endocrinologist, RBH Keith Hilston, Podiatrist, BHFT High mortality and morbidity Complex condition, longterm
More informationNeuropathic pain: diagnosis, pathophysiological mechanisms, and treatment
Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment Ralf Baron, Andreas Binder, Gunnar Wasner Neuropathic pain develops as a result of lesions or disease affecting the somatosensory
More informationPAIN MEDICINE FOR THE NON-PAIN SPECIALIST 2017
PAIN MEDICINE FOR THE NON-PAIN SPECIALIST 2017 FEBRUARY 16-18, 2017 JW MARRIOTT DESERT SPRINGS RESORT & SPA PALM DESERT, CALIFORNIA Learn the latest treatment strategies and multidisciplinary management
More informationLong-term neuropathic pain
Long-term neuropathic pain Per Hansson, Professor, MD, DMSci, DDS, specialist in neurology (and pain management) -Dept of Pain Management and Research, Oslo University Hospital, Oslo, Norway - Norwegian
More informationPharmacologic Aspect of Neuropathic Pain
September 911, 2015, Banda Aceh, Indonesia Pharmacologic Aspect of Neuropathic Pain 1 Endang Mutiawati, 2 Imai Indra, 3 Syahrul, 4 *Mulyadi 1 Department of Neurology, Faculty of Medicine, Syiah Kuala University,
More informationCapsaicin cutaneous patch
New Medicines Profile August 2010 Issue. 10/03 cutaneous patch Concise evaluated information to support the managed entry of new medicines in the NHS Summary cutaneous patch (Qutenza ) is licensed for
More informationScottish Medicines Consortium
Scottish Medicines Consortium duloxetine 30mg and 60mg capsules (Cymbalta ) No. (285/06) Eli Lilly and Company Limited/Boehringer Ingelheim 4 August 2006 The Scottish Medicines Consortium has completed
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Quality ID #126 (NQF 0417): Diabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy Neurological Evaluation National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL
More informationDiabetic Peripheral Neuropathic Pain: Evaluating Treatment Options
Diabetic Peripheral Neuropathic Pain: Evaluating Treatment Options Ramon L. Cuevas-Trisan, MD Disclosures Speakers Bureau/Honoraria: Allergan, Ipsen 1 Learning Objectives Discuss practical approaches to
More informationTreatment of Neuropathic Pain
Treatment of Neuropathic Pain Kristen Jefferies, Pharm.D. 1 ABSTRACT Neuropathic pain is a common symptom associated with peripheral neuropathy and can be as or more disabling than the effects of nerve
More informationChronic Pain Overview. Mark S. Wallace, M.D. Professor of Clinical Anesthesiology University of California, San Diego
Chronic Pain Overview Mark S. Wallace, M.D. Professor of Clinical Anesthesiology University of California, San Diego Physiology of Pain Perception CORE Transduction Transmission Modulation Perception Interpretation
More informationThe Challenges of Neuropathic Pain. Andrew SC Rice
The Challenges of Neuropathic Pain Andrew SC Rice What is neuropathic pain? Challenges in the use of animal models to study neuropathic pain Ongoing systematic review and meta-analysis of neuropathy animal
More informationDIABETIC FOOT SCOPE OF THE PROBLEM. Hanan Gawish, Mansoura University Egypt Representative of the IWGDF
DIABETIC FOOT SCOPE OF THE PROBLEM Hanan Gawish, Mansoura University Egypt Representative of the IWGDF Agenda Definition of DF Diabetic Foot among Diabetes complication Risk factors for amputation Risk
More informationINTERACTIVE QUESTIONS
INTERACTIVE QUESTIONS Pathophysiology What is pain? Pathophysiology Does everyone feel pain the same way? Pathophysiology From a practical point of view, how do you classify pain? Pathophysiology What
More informationRefractory Central Neurogenic Pain in Spinal Cord Injury. Case Presentation
Refractory Central Neurogenic Pain in Spinal Cord Injury Case Presentation Edwin B. George, MD, PhD Wayne State University John D. Dingell VAMC 2012 Disclosures This continuing education activity is managed
More informationThe Diabetic Foot Screen and Management Foundation Series of Modules for Primary Care
The Diabetic Foot Screen and Management Foundation Series of Modules for Primary Care Anita Murray - Senior Podiatrist Diabetes, SCH Learning Outcomes Knowledge of the Model of Care For The Diabetic Foot
More informationPainful diabetic neuropathy
Rajinikanth Sundara Rajan MD FRCA EDRA Lorraine de Gray MD LLM (Medical Law) FRCA FFPMRCA Emad George MD FRCP (UK) PG Cert Med Ed Matrix reference 1A02, 2E03, 3E00 Key points Painful diabetic neuropathy
More informationDiabetic Neuropathy WHAT IS DIABETIC NEUROPATHY?
Diabetic Neuropathy WHAT IS DIABETIC NEUROPATHY? D iabetic neuropathy is actually a group of nerve diseases. All of these disorders affect the peripheral nerves, that is, the nerves that are outside the
More informationUnitedHealthcare Pharmacy Clinical Pharmacy Programs
UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2018 P 3019-9 Program Step Therapy Medication Lyrica capsules, Lyrica Solution, Lyrica CR tablets* (pregabalin) P&T Approval Date 1/08,
More informationAcute Pain Management
Idaho Society of Health-System Pharmacists Acute Pain Management Alex Ham, PharmD and Monica McLain, PharmD Saint Alphonsus Regional Medical Center PGY1 Residents September 28, 2018 Disclosures Neither
More informationClinical Review. Diagnosis and management of neuropathic pain. R Freynhagen, 1 M I Bennett 2. For the full versions of these articles see bmj.
For the full versions of these articles see bmj.com Clinical Review Diagnosis and management of R Freynhagen, 1 M I Bennett 2 1 Department of Anaesthesiology, Critical Care Medicine, Pain Therapy & Palliative
More informationComplications of Diabetes: Screening and Prevention
Complications of Diabetes: Screening and Prevention Dr Steve Cleland Consultant Physician GGH and QEUH Diabetes Staff Education Course June 17 Diabetic Complications Microvascular: Retinopathy Nephropathy
More informationJong Chul Won, 1 Yong-Jin Im, 2 Ji-Hyun Lee, 3 Chong Hwa Kim, 4 Hyuk Sang Kwon, 5 Bong-Yun Cha, 5 and Tae Sun Park 6. 1.
Hindawi Journal of Diabetes Research Volume 2017, Article ID 5751687, 9 pages https://doi.org/10.1155/2017/5751687 Research Article Clinical Phenotype of Diabetic Peripheral Neuropathy and Relation to
More informationSpasticity. Pain and Spasticity Management in SCI Nov 23 rd, /19/17
Pain and Spasticity Management in SCI Nov 23 rd, 2017 Phichamon Khanittanuphong, MD Rehabilitation Division Department of Orthopaedic Surgery and Physical Medicine Faculty of Medicine, Prince of Songkla
More informationManaging neuropathic pain
Managing neuropathic pain Highlights from the 2014 Neuropathic Pain Certification Course Neuropathic pain (NeP) remains one of the most challenging neurological problems encountered in clinical practice
More informationNerveCheck for the Detection of Sensory Loss and Neuropathic Pain in Diabetes
DIABETES TECHNOLOGY & THERAPEUTICS Volume 18, Number 12, 2016 Mary Ann Liebert, Inc. DOI: 10.1089/dia.2016.0279 ORIGINAL ARTICLE NerveCheck for the Detection of Sensory Loss and Neuropathic Pain in Diabetes
More informationPharmacotherapy for Neuropathic Pain in Japan
Review Pharmacotherapy for Neuropathic Pain in Japan Ritsuko Masuda, Junko Ajimi and Tomohiko Murata Department of Anesthesiology, Tokai University Hachioji Hospital, Tokyo, Japan Neuropathic pain (NeP)
More informationClinical practice guidelines for the management of neuropathic pain: a systematic review
Deng et al. BMC Anesthesiology (2016) 16:12 DOI 10.1186/s12871-015-0150-5 RESEARCH ARTICLE Open Access Clinical practice guidelines for the management of neuropathic pain: a systematic review Yunkun Deng
More informationAcute Pain NETP: SEPTEMBER 2013 COHORT
Acute Pain NETP: SEPTEMBER 2013 COHORT Pain & Suffering an unpleasant sensory & emotional experience associated with actual or potential tissue damage, or described in terms of such damage International
More informationCHAPTER 10 THE SOMATOSENSORY SYSTEM
CHAPTER 10 THE SOMATOSENSORY SYSTEM 10.1. SOMATOSENSORY MODALITIES "Somatosensory" is really a catch-all term to designate senses other than vision, hearing, balance, taste and smell. Receptors that could
More informationBig News in Small Fiber Neuropathies
Big News in Small Fiber Neuropathies Charles E. Argoff, M.D. Professor of Neurology Albany Medical College Director, Comprehensive Pain Center Director, Pain Management Fellowship Albany Medical Center
More informationPostherpetic neuralgia *
Section 1 Chapter 1 Neurological Disorders Postherpetic neuralgia * Alan David Kaye and Charles E. Argoff Case study A 78-year-old male with a history of postherpetic neuralgia (PHN) as well as hypertension
More informationTHE FORGOTTEN COMPLICATION M. Pfeifer
Diabetic Neuropathy THE FORGOTTEN COMPLICATION M. Pfeifer P 1 The Burden of Diabetic Peripheral Neuropathy Most common peripheral neuropathy in the developed nations Major contributor to the hospital rate
More informationLYRICA FOR THE TREATMENT OF NEUROPATHIC PAIN DISORDERS
Volume 20, Issue 7 April 2005 LYRICA FOR THE TREATMENT OF NEUROPATHIC PAIN DISORDERS Tanja Lepir, Pharm.D. Candidate Nervous system dysfunction leading to neuropathic pain can occur from many causes: infection,
More informationManagement of Neuropathic pain
Management of Neuropathic pain Ravi Parekodi Consultant in Anaesthetics and Pain Management 08/04/2014 Ref: BJA July2013, Map of Medicine2013, Pain Physician 2007, IASP 2012, Nice guideline 2013 Aims Highlight
More informationBalgrist Symposium zum Diabetischen Fuss. Der Charcot-Fuss Oktober diabetic neuropathies. symptoms. signs. sensory disorders.
symptoms sensory disorders spontaneous paraesthesia tingling burning by touch, pressure dysaesthesia sign pain continuous boring cutting drawing paroxysmal lancinating neuralgiform causalgic fluctuating,
More informationCHAPTER 4 PAIN AND ITS MANAGEMENT
CHAPTER 4 PAIN AND ITS MANAGEMENT Pain Definition: An unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. Types of Pain
More informationTITLE: Gabapentin for HIV-associated Neuropathic Pain: A Review of the Clinical Effectiveness
TITLE: Gabapentin for HIV-associated Neuropathic Pain: A Review of the Clinical Effectiveness DATE: 22 January 2016 CONTEXT AND POLICY ISSUES Neuropathic pain can be severe and debilitating and results
More informationNervecheck for the detection of early sensory loss and neuropathic pain in diabetes. Running head: NerveCheck for diabetic neuropathy
Nervecheck for the detection of early sensory loss and neuropathic pain in diabetes Running head: NerveCheck for diabetic neuropathy G. Ponirakis 1,3, M.N. Odriozola 2, S. Odriozola 2, I.N. Petropoulos
More informationABSTRACT KEY WORDS KATHMANDU UNIVERSITY MEDICAL JOURNAL. Page 120. Background
Prevalence of Sensory Neuropathy in Type 2 Diabetes Mellitus and Its Correlation with Duration of Disease Karki DB, 1 Yadava SK, 1 Pant S, 2 Thusa N, 1 Dangol E, 1 Ghimire S 1 ABSTRACT Background 1 Department
More informationNEUROFIX S MISSION & VISION
NEUROFIX S MISSION & VISION MISSION Neurofix aims to discover and develop innovative therapies for the treatment of neurological disorders. Our main focus now is Spinal Cord Injury. VISION Spinal Cord
More informationSurgical Management of Complicated Peripheral Neuropathies in Diabetic Patients
Med. J. Cairo Univ., Vol. 83, No. 2, September: 27-32, 2015 www.medicaljournalofcairouniversity.net Surgical Management of Complicated Peripheral Neuropathies in Diabetic Patients AMR M. SAFWAT, M.D.*;
More informationPharmacology of Pain Transmission and Modulation
Pharmacology of Pain Transmission and Modulation 2 Jürg Schliessbach and Konrad Maurer Nociceptive Nerve Fibers Pain is transmitted to the central nervous system via thinly myelinated Aδ and unmyelinated
More informationWhich TCAs and what dosing is recommended for the different types of chronic non-cancer pain as recommended in the chart for key message 1?
Which TCAs and what dosing is recommended for the different types of chronic non-cancer pain as recommended in the chart for key message 1? Tricyclic antidepressants (TCAs) are agents approved for the
More informationA Caress or a Slap: Understanding Sensory Amplification Systems in Chronic Pain
A Caress or a Slap: Understanding Sensory Amplification Systems in Chronic Pain Charles E. Argoff, MD, CPE Disclosure Consultant/Independent Contractor Depomed, Teva, Endo, Purdue, Quest, Grünenthal, Pfizer,
More information